Jenburkt Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Jenburkt Pharmaceuticals Ltd. on BSE

Load latest

Jenburkt Pharmaceuticals Ltd.

20 Jun 2025

1188.25

3.09%

Corp. Action

Jenburkt Pharmaceuticals Ltd - 524731 - Intimation Of Record Date And Cut-Off Date

BSE India

The Company has fixed Friday, 11th July, 2025, as the Record date for the payment of Dividend for the financial year 2024-25 as well as cut- off date for remote e-voting & e-voting during the 40th AGM.

pdf

Jenburkt Pharmaceuticals Ltd.

20 Jun 2025

1188.25

3.09%

AGM

Jenburkt Pharmaceuticals Ltd - 524731 - Notice Of The 40Th Annual General Meeting Of The Company …

BSE India

Notice of the 40th Annual General Meeting Schedule to be held on Friday, 18th July, 2025 through VC/OAVM.

pdf

Jenburkt Pharmaceuticals Ltd.

20 Jun 2025

1188.25

3.09%

Corp. Note

Jenburkt Pharmaceuticals Ltd - 524731 - Reg. 34 (1) Annual Report.

BSE India

Submission of the Annual Report for the FY 2024-25, containing Audited Financial Statements, Auditors Report and Directors Report and the Notice convening 40th Annual General Meeting of the Company.

pdf

Jenburkt Pharmaceuticals Ltd.

18 Jun 2025

1188.25

3.09%

SAST

Jenburkt Pharmaceuticals Ltd - 524731 - Closure of Trading Window

BSE India

Intimation of closure of trading window of Jenburkt Pharmaceuticals Limited as per the SEBI(PIT) Regulations, 2015.

pdf

Jenburkt Pharmaceuticals Ltd.

03 Jun 2025, 03:33PM

1188.25

3.09%

Company Update

Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper advertisement for giving notice for the purpose of transfer of unclaimed dividend and corresponding equity shares of the Company to IEPFA.

pdf

Jenburkt Pharmaceuticals Ltd.

21 May 2025

1188.25

3.09%

Company Update

Jenburkt Pharmaceuticals Ltd - 524731 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Annual Secretarial Compliance Report for the financial Year ended on 31st March, 2025.

pdf

Jenburkt Pharmaceuticals Ltd.

21 May 2025

1188.25

3.09%

Company Update

Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication of Standalone Audited Financial Result for the quarter and financial Year ended on 31st March, 2025.

pdf

Jenburkt Pharmaceuticals Ltd.

21 May 2025

1188.25

3.09%

Corp. Note

Jenburkt Pharmaceuticals Ltd - 524731 - Integrated Filing (Financial)

BSE India

Integrated Filing (Financial) for the quarter and financial year ended on 31st March, 2025.

pdf

Jenburkt Pharmaceuticals Ltd.

20 May 2025

1188.25

3.09%

Corp. Note

Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Dividend Updates

BSE India

The Board of Directors of the Company recomended a dividend of Rs.18/- (180%) per equity share of Rs. 10/- each on 4413300 equity shares of the Company, for the Financial year 2024-25, subject to the approval of members at the ensuing 40th Annual General Meeting of the Company.

pdf

Jenburkt Pharmaceuticals Ltd.

20 May 2025

1188.25

3.09%

Company Update

Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Re-appointment of Chairman and Managing Director of the Company, Subject to the Approval of the Members at the ensuing 40th Annual General Meeting of the Company.

pdf

Is Jenburkt Pharmaceuticals Ltd. worth buying?

27 Votes:

Buy 62.96%

Sell 22.22%

Hold 14.81%